Cargando…
FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease
Type 2 diabetes (T2D) is associated with increased risk of cardiovascular disease (CVD). As disturbed angiogenesis and endothelial dysfunction are strongly implicated in T2D and CVD, we aimed to investigate the association between a novel anti-angiogenic protein, FK506-binding protein like (FKBPL),...
Autores principales: | Januszewski, Andrzej S., Watson, Chris J., O’Neill, Vikki, McDonald, Kenneth, Ledwidge, Mark, Robson, Tracy, Jenkins, Alicia J., Keech, Anthony C., McClements, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730138/ https://www.ncbi.nlm.nih.gov/pubmed/33303872 http://dx.doi.org/10.1038/s41598-020-78676-6 |
Ejemplares similares
-
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility
por: Chhor, Michael, et al.
Publicado: (2023) -
FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function
por: Alqudah, Abdelrahim, et al.
Publicado: (2021) -
FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis
por: Yakkundi, Anita, et al.
Publicado: (2015) -
Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice
por: Obradović, Danilo D., et al.
Publicado: (2022) -
The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway
por: Yakkundi, Anita, et al.
Publicado: (2013)